Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × Eflornithine × Clear all

NCT00006079 2018-10-25

Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

Phase 2 Completed

GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions